Table 2.
Primary Outcomes | Surrogate Outcomes |
---|---|
Reflect unequivocal evidence of tangible benefit to the patient | Include measures that are not of direct practical importance but are believed to reflect outcomes that are important as part of a disease/treatment process |
Examples | Corresponding examples |
● Tooth survival | ● Pocket depth |
● Secondary caries | ● Open margins |
● Implant survival | ● Peri-implant bone level |
● Patient satisfaction | ● Prosthesis retention/support |
Endpoints are “harder” and difficult to measure and studies can be more expensive. | Endpoints are “softer” and easier to measure and studies are relatively inexpensive. |
Can have a direct impact on changes in clinical practice and/or changes in public health policies. | Do not have a direct impact on changes in clinical practice or changes in public health policies. |
Note: Adapted from Dent Clin North Am, 58(1), Bidra AS. Evidence-based prosthodontics: fundamental considerations, limitations, and guidelines. Dent Clin North Am. 1–17. Copyright 2014, with permission from Elsevier.35